Fingerprint
Dive into the research topics of 'Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer
Stephen Kalscheuer, Vidhi Khanna, Hyunjoon Kim, Sihan Li, Deepali Sachdev, Arthur DeCarlo, Da Yang, Jayanth Panyam
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations